Rheumatologic Disease Clinical Trials

7 recruiting

Rheumatologic Disease Trials at a Glance

11 actively recruiting trials for rheumatologic disease are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in São Paulo, Alexandroupoli, and Aventura. Lead sponsors running rheumatologic disease studies include University of Sao Paulo General Hospital, Institut National de la Santé Et de la Recherche Médicale, France, and European Alliance of Associations in Rheumatology.

Browse rheumatologic disease trials by phase

Treatments under study

About Rheumatologic Disease Clinical Trials

Looking for clinical trials for Rheumatologic Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Rheumatologic Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Rheumatologic Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

A Study of SPY072 in Rheumatic Disease

Rheumatoid ArthritisPsoriatic ArthritisRheumatic Diseases+5 more
Spyre Therapeutics, Inc.285 enrolled57 locationsNCT07148414
Recruiting
Not Applicable

Testimonials and Navigation in Rheumatology

Autoimmune DiseasesRheumatologic Disease
University of Alabama at Birmingham1,170 enrolled3 locationsNCT06469788
Recruiting
Phase 4

Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases

Autoimmune Rheumatologic Disease
University of Sao Paulo General Hospital263 enrolled2 locationsNCT07252804
Recruiting
Phase 1Phase 2

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Rheumatoid Arthritis (RA)Autoimmune Rheumatologic DiseaseDiffuse Cutaneous Systemic Sclerosis+1 more
Quell Therapeutics Limited16 enrolled6 locationsNCT07473154
Recruiting
Phase 4

Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases

Autoimmune Rheumatologic Disease
University of Sao Paulo General Hospital114 enrolled1 locationNCT07252791
Recruiting

EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey

Musculoskeletal DiseasesRheumatologic Disease
European Alliance of Associations in Rheumatology1,000 enrolled1 locationNCT06461000
Recruiting

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Autoimmune HepatitisSystemic Lupus ErythematosusHemophagocytic Lymphohistiocytoses+17 more
Institut National de la Santé Et de la Recherche Médicale, France500 enrolled1 locationNCT04902807
Recruiting

Psorcast Mobile Study

Joint PainPsoriasisPsoriatic Arthritis+6 more
Sage Bionetworks1,000 enrolled1 locationNCT05621369
Recruiting

Rheumatology Diet Study

Rheumatoid ArthritisFibromyalgiaAnkylosing Spondylitis+8 more
University of Central Florida500 enrolled1 locationNCT06339957
Recruiting

Greater Manchester CARDIOvascular Pathology in Immune-Mediated Inflammatory Diseases

Cardiovascular DiseasesRheumatologic Disease
University of Manchester325 enrolled1 locationNCT06600737
Recruiting

A Clinical Study to Map the HLA Genomic Region in the Greek Population

Cardiovascular DiseasesMetabolic DiseaseHealthy+7 more
Athens LifeTech Park12,000 enrolled8 locationsNCT06227468